{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:13:09Z","timestamp":1780524789807,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.bcp.2015.09.023","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T10:35:33Z","timestamp":1445164533000},"page":"522-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism"],"prefix":"10.1016","volume":"98","author":[{"given":"Giulia","family":"Zanetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8955-7240","authenticated-orcid":false,"given":"Domenico","family":"Azarnia Tehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4127-254X","authenticated-orcid":false,"given":"Marcon","family":"Pirazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Binz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford C.","family":"Shone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florigio","family":"Lista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Rossetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-5688","authenticated-orcid":false,"given":"Cesare","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.09.023_bib0005","first-page":"1","article-title":"Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes","volume":"364","author":"Hill","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0072-9752(07)01511-4","article-title":"Botulism","volume":"91","author":"Johnson","year":"2008","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0020","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0022-3565(24)36519-X","article-title":"In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches","volume":"280","author":"Coffield","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.09.023_bib0025","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.clinph.2012.11.004","article-title":"Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study","volume":"124","author":"Eleopra","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2015.04.015","article-title":"Activity of botulinum neurotoxin type D (strain 1873) in human neurons","volume":"101","author":"Pellett","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2015.09.023_bib0035","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2015.09.023_bib0040","first-page":"61083","article-title":"Possession, use, and transfer of select agents and toxins; biennial review. Final rule","volume":"77","author":"Centers for Disease Control and Prevention DoHaHS","year":"2012","journal-title":"Fed. Regist."},{"key":"10.1016\/j.bcp.2015.09.023_bib0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2015.09.023_bib0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/307457a0","article-title":"Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization","volume":"307","author":"Dolly","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.09.023_bib0055","first-page":"61","article-title":"Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity","volume":"364","author":"Rummel","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tibs.2014.08.009","article-title":"Botulinum neurotoxins: new questions arising from structural biology","volume":"39","author":"Kammerer","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bcp.2015.09.023_bib0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12035-013-8423-9","article-title":"Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction","volume":"48","author":"Colasante","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0070","doi-asserted-by":"crossref","first-page":"35966","DOI":"10.1074\/jbc.M111.283879","article-title":"Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism","volume":"286","author":"Harper","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.09.023_bib0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3565(25)33626-8","article-title":"Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins","volume":"225","author":"Simpson","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.09.023_bib0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2015.09.023_bib0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxicon.2013.01.007","article-title":"Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function","volume":"75","author":"Fischer","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2015.09.023_bib0090","article-title":"On the translocation of botulinum and tetanus neurotoxins across the membrane of acidic intracellular compartments","author":"Pirazzini","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"10.1016\/j.bcp.2015.09.023_bib0095","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1462-5822.2011.01654.x","article-title":"Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons","volume":"13","author":"Pirazzini","year":"2011","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0100","doi-asserted-by":"crossref","first-page":"29604","DOI":"10.1074\/jbc.M703619200","article-title":"Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes","volume":"282","author":"Fischer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.09.023_bib0105","doi-asserted-by":"crossref","first-page":"20838","DOI":"10.1016\/S0021-9258(19)36861-9","article-title":"A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly","volume":"268","author":"de Paiva","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.09.023_bib0110","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1128\/iai.58.12.4136-4141.1990","article-title":"An intact interchain disulfide bond is required for the neurotoxicity of tetanus toxin","volume":"58","author":"Schiavo","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bcp.2015.09.023_bib0115","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0041-0101(93)90208-Z","article-title":"Disulfide formation in reduced tetanus toxin by thioredoxin: the pharmacological role of interchain covalent and noncovalent bonds","volume":"31","author":"Kistner","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2015.09.023_bib0120","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2015.09.023_bib0125","doi-asserted-by":"crossref","first-page":"23784","DOI":"10.1016\/S0021-9258(20)80452-9","article-title":"Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E","volume":"268","author":"Schiavo","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.09.023_bib0130","first-page":"139","article-title":"Clostridial neurotoxin light chains: devices for SNARE cleavage mediated blockade of neurotransmission","volume":"364","author":"Binz","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00018-013-1380-7","article-title":"The blockade of the neurotransmitter release apparatus by botulinum neurotoxins","volume":"71","author":"Pantano","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2015.09.023_bib0140","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.celrep.2014.08.017","article-title":"Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins","volume":"8","author":"Pirazzini","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2015.09.023_bib0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.molmed.2014.09.005","article-title":"Redox regulation of botulinum neurotoxin toxicity: therapeutic implications","volume":"20","author":"Montal","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2015.09.023_bib0150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/toxins2040665","article-title":"Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering","volume":"2","author":"Binz","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2015.09.023_bib0155","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1158\/0008-5472.CAN-05-3310","article-title":"Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity","volume":"66","author":"Lu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.09.023_bib0160","doi-asserted-by":"crossref","first-page":"25284","DOI":"10.1074\/jbc.M414645200","article-title":"Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity","volume":"280","author":"Fang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.09.023_bib0165","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0006-2952(97)00597-2","article-title":"Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides","volume":"55","author":"Kirkpatrick","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0170","doi-asserted-by":"crossref","DOI":"10.1259\/bjr\/34180435","article-title":"The thioredoxin system: a key target in tumour and endothelial cells","volume":"81","author":"Mukherjee","year":"2008","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0175","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1073\/pnas.122061399","article-title":"Ebselen a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant","volume":"99","author":"Zhao","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2015.09.023_bib0180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.febslet.2012.11.007","article-title":"The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals","volume":"587","author":"Pirazzini","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2015.09.023_bib0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","article-title":"The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction","volume":"51","author":"Rummel","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0190","doi-asserted-by":"crossref","first-page":"30865","DOI":"10.1074\/jbc.M403945200","article-title":"Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G","volume":"279","author":"Rummel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.09.023_bib0195","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1471-4159.2004.02844.x","article-title":"Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates","volume":"91","author":"Bade","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2015.09.023_bib0200","first-page":"143","article-title":"Growth of clostridia and preparation of their neurotoxins","volume":"195","author":"Shone","year":"1995","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0205","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1242\/jcs.01218","article-title":"Snake presynaptic neurotoxins with phospholipase A2 activity induce punctate swellings of neurites and exocytosis of synaptic vesicles","volume":"117","author":"Rigoni","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2015.09.023_bib0210","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","article-title":"A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice","volume":"39","author":"Aoki","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2015.09.023_bib0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxicon.2013.05.004","article-title":"The rat digit abduction score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis","volume":"71","author":"Broide","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2015.09.023_bib0220","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/bi3004928","article-title":"Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pH","volume":"51","author":"Sun","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2015.09.023_bib0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.chom.2011.06.012","article-title":"Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly","volume":"10","author":"Sun","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bcp.2015.09.023_bib0230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.STR.29.1.12","article-title":"Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial: Ebselen study group","volume":"29","author":"Yamaguchi","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.bcp.2015.09.023_bib0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006123-199802000-00038","article-title":"Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage","volume":"42","author":"Saito","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bcp.2015.09.023_bib0240","first-page":"2015","article-title":"On botulinum neurotoxin variability","author":"Montecucco","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.bcp.2015.09.023_bib0245","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.resmic.2014.09.007","article-title":"Historical and current perspectives on Clostridium botulinum diversity","volume":"166","author":"Smith","year":"2015","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0250","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.toxicon.2009.09.005","article-title":"Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins","volume":"55","author":"Torii","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2015.09.023_bib0255","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1044-7431(02)00016-7","article-title":"Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation","volume":"22","author":"Meunier","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bcp.2015.09.023_bib0260","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/mus.21343","article-title":"Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg","volume":"40","author":"Carli","year":"2009","journal-title":"Muscle Nerve"},{"issue":"Suppl. 8","key":"10.1016\/j.bcp.2015.09.023_bib0265","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/mds.20010","article-title":"Different types of botulinum toxin in humans","volume":"19","author":"Eleopra","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bcp.2015.09.023_bib0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2015.06.021","article-title":"In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1\u20135","author":"Pellett","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2015.09.023_bib0275","first-page":"179","article-title":"Persistence of Botulinum neurotoxin inactivation of nerve function","volume":"364","author":"Shoemaker","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0280","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/mr.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts","volume":"46","author":"Gill","year":"1982","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.bcp.2015.09.023_bib0285","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/jpet.109.156901","article-title":"Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a","volume":"331","author":"Thyagarajan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2015.09.023_bib0290","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/597310","article-title":"Persistence of botulinum toxin in patients\u2019 serum: Alaska, 1959\u20132007","volume":"199","author":"Fagan","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2015.09.023_bib0295","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/592574","article-title":"International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice","volume":"47","author":"Sheth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bcp.2015.09.023_bib0300","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10637-012-9846-2","article-title":"A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers","volume":"31","author":"Baker","year":"2013","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.bcp.2015.09.023_bib0305","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00280-010-1343-8","article-title":"A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination","volume":"67","author":"Ramanathan","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0310","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bcp.2013.08.028","article-title":"The early research and development of ebselen","volume":"86","author":"Parnham","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0315","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/13543784.9.3.607","article-title":"Ebselen prospective therapy for cerebral ischaemia","volume":"9","author":"Parnham","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bcp.2015.09.023_bib0320","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","article-title":"Curcumin as Curecumin: from kitchen to clinic","volume":"75","author":"Goel","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2015.09.023_bib0325","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-6997(24)01472-8","article-title":"The effects of plant flavonoids on mammalian cells:implications for inflammation, heart disease, and cancer","volume":"52","author":"Middleton","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2015.09.023_bib0330","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2007-1827","article-title":"Global occurrence of infant botulism, 1976\u20132006","volume":"122","author":"Koepke","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.bcp.2015.09.023_bib0335","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.me.31.020180.002545","article-title":"Infant botulism","volume":"31","author":"Arnon","year":"1980","journal-title":"Annu. Rev. Med."}],"updated-by":[{"DOI":"10.1016\/j.bcp.2016.07.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215006541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215006541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:59:38Z","timestamp":1757768378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215006541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0006295215006541"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.09.023","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bcp.2016.07.006","asserted-by":"object"}]},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}